Tubal reversal surgery is a reconstructive procedure within reproductive endocrinology and infertility designed to repair occluded or ligated Fallopian tubes. The primary objective is restoring standard gamete transport, enabling the egg and sperm to meet naturally within the tubal ampulla and allowing the resulting embryo to travel into the uterine cavity. The procedure involves microsurgical excision of scarred segments followed by precise multi-layer alignment of the tubal lumen.

Tubal reversal surgery is performed under general anaesthesia using a minilaparotomy, traditional laparoscopy, or robotic-assisted approach. The surgeon isolates the proximal and distal segments of the ligated Fallopian tube and injects dilute indigo carmine or methylene blue dye into the uterine cavity to confirm patency up to the obstruction. Scarred, occluded ends are excised microsurgically until healthy, patent lumen is identified on both sides. A temporary epidural catheter or flexible stent is guided through the lumen to maintain alignment. Using micro-instruments under 10x to 20x magnification, the inner muscular layer (myosalpinx) is reapproximated with 4 to 6 interrupted 8-0 or 9-0 absorbable microsutures, carefully avoiding mucosa-piercing to prevent tissue trauma. The outer serosal layer is then closed separately to minimize tension and reduce postoperative adhesion formation. Patency is re-tested with chromopertubation, after which instruments are removed and abdominal incisions are closed in layers.

Key evidence-based clinical advantages of tubal reversal surgery include the potential for multiple natural pregnancies following a single intervention, elimination of the need for ongoing fertility medications, and avoidance of the increased risks of high-order multiple gestations associated with ovarian hyperstimulation in assisted reproduction. According to the American Society for Reproductive Medicine (ASRM Practice Committee, 2021), patients under 35 with adequate tubal length achieve high cumulative intrauterine pregnancy rates over 12 to 24 months post-operatively.

Immediate recovery involves 2 to 4 hours of post-anaesthesia monitoring prior to same-day discharge. Mild to moderate incisional discomfort and shoulder pain from laparoscopic gas insufflation typically resolve within 48 to 72 hours. Most individuals resume sedentary work within 7 days and full physical activity, including heavy lifting and sexual intercourse, within 2 to 4 weeks, depending on whether the approach was laparoscopic, robotic, or minilaparotomy.

Tubal reversal surgery is performed to correct iatrogenic mechanical tubal obstruction resulting from previous tubal ligation, tubal cauterisation, mechanical clipping, or silastic ring placement. It is indicated for women seeking post-sterilisation fertility restoration who desire spontaneous conception without relying on repeated cycles of assisted reproductive technology.

Preoperative preparation requires a complete reproductive evaluation of both partners. Female evaluation includes assessing ovarian reserve via anti-Müllerian hormone (AMH) testing and antral follicle count (AFC), along with obtaining prior operative and pathology reports from the tubal ligation to determine the original sterilization method. A preoperative pelvic ultrasound evaluates for coexisting uterine fibroids or ovarian cysts, while a formal semen analysis rules out male factor infertility. Standard presurgical fasting is enforced for 8 hours prior to procedure. Anticoagulant medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and specific herbal supplements are discontinued 7 to 14 days prior to surgery under medical supervision. Prophylactic single-dose intravenous antibiotics are administered prior to incision.

Complications associated with tubal reversal surgery include standard surgical risks and procedure-specific reproductive risks. Common, mild side effects include incisional soreness, mild abdominal bloating, minor vaginal spotting, and transient shoulder tip pain from laparoscopy. Uncommon risks include surgical site infection, pelvic hematoma, and postoperative adhesion formation that may cause tubal re-occlusion. Rare but serious complications comprise visceral organ injury (bowel, bladder, or major vascular structures) requiring exploratory laparotomy, conversion from minimally invasive to open surgery, anesthetic reactions, and deep vein thrombosis. The primary long-term clinical risk is ectopic pregnancy, occurring in approximately 3% to 8% of post-reversal pregnancies, necessitating prompt early transvaginal ultrasound monitoring upon confirmation of pregnancy.

The clinical journey begins with a detailed diagnostic workup, including an operative report review, semen analysis, and ovarian reserve assessment. On the day of surgery, the patient undergoes outpatient microsurgery or robotic-assisted tubal reanastomosis under general anaesthesia. Early recovery spans 1 to 2 weeks, during which physical exertion is limited. Longitudinal follow-up includes early monitoring for pregnancy and immediate transvaginal ultrasonography upon a positive result to rule out ectopic implantation.